pacemaker is a small piece of equipment that is positioned in the abdomen or chest to help control any abnormal heart rates or rhythms. This tool utilizes electrical pulses to prompt the heart to beat at regular rates. These devices are used in treating arrhythmias. A pacemaker can ease some symptoms of arrhythmia, such as fainting and fatigue. This device can also help a patient, who has abnormal heart rates, to continue a healthy & more active lifestyle. According to a report published by Grand View Research Inc., the global pacemaker market is anticipated to reach USD 12.3 billion by 2025.
View summary of this report , Click Here
The Micra Transcatheter Pacing System (TPS):
The world’s smallest pacemaker, Micra Transcatheter Pacing System (TPS), which is as big as a large capsule of vitamin, provides the highly developed pacing technology. As per records, the device has also been implanted successfully for the first time in a patient in the United States.
Approved by the United States Food & Drug Administration (FDA), TPS is a novel & innovative type of heart device that provides the most sophisticated pacing technology at almost 1/10th the size of conventional pacemakers and is also the only leadless pacemaker device approved for use in the United States.
Other Features of TPS:
Micra transcatheter pacing system is tiny enough to be carried with the help of a catheter and fixed straight into the heart, providing a safe substitute to the traditional pacemakers eliminating the complexities related to leads. The device also lets us automatically adjust pacing therapy depending on the activity levels of a patient and another plus point is that its battery can last almost up to 10 years!
Global Pacemaker Market Overview:
The global pacemaker market is expected to grow at a healthy CAGR of over 9.2 %from 2014 to 2025. The growing occurrences of cardiac conditions along with the availability of clinical coverage are the major growth driving factors for the global market for pacemakers. In addition to this, technological advancements in such devices are also boosting the expansion of this segment. Some of the major players in the global market include MEDICO S.p.A.; Boston Scientific Corp.; Cordis Inc.; BIOTRONIK Inc.; and ZOLL Medical Corporation.
Sample Request OF These Report : https://goo.gl/vSuZpy
The Micra Transcatheter Pacing System (TPS):
The world’s smallest pacemaker, Micra Transcatheter Pacing System (TPS), which is as big as a large capsule of vitamin, provides the highly developed pacing technology. As per records, the device has also been implanted successfully for the first time in a patient in the United States.
Approved by the United States Food & Drug Administration (FDA), TPS is a novel & innovative type of heart device that provides the most sophisticated pacing technology at almost 1/10th the size of conventional pacemakers and is also the only leadless pacemaker device approved for use in the United States.
Other Features of TPS:
Micra transcatheter pacing system is tiny enough to be carried with the help of a catheter and fixed straight into the heart, providing a safe substitute to the traditional pacemakers eliminating the complexities related to leads. The device also lets us automatically adjust pacing therapy depending on the activity levels of a patient and another plus point is that its battery can last almost up to 10 years!
Global Pacemaker Market Overview:
The global pacemaker market is expected to grow at a healthy CAGR of over 9.2 %from 2014 to 2025. The growing occurrences of cardiac conditions along with the availability of clinical coverage are the major growth driving factors for the global market for pacemakers. In addition to this, technological advancements in such devices are also boosting the expansion of this segment. Some of the major players in the global market include MEDICO S.p.A.; Boston Scientific Corp.; Cordis Inc.; BIOTRONIK Inc.; and ZOLL Medical Corporation.
Sample Request OF These Report : https://goo.gl/vSuZpy
ConversionConversion EmoticonEmoticon